SREBF1 and breast carcinoma: In breast cancer, NONO increased nuclear sterol regulatory element-binding protein (SREBP)−1a protein stability and stimulated SREBP-1a–mediated transcription of lipogenic genes and lipid production, thus promoting breast cancer growth [13].